Cumberland Partners Ltd Buys 1,500 Shares of HCA Healthcare, Inc. $HCA

Cumberland Partners Ltd lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 25.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,500 shares of the company’s stock after buying an additional 1,500 shares during the period. Cumberland Partners Ltd’s holdings in HCA Healthcare were worth $3,196,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. Norges Bank bought a new position in HCA Healthcare in the second quarter valued at $1,152,408,000. Viking Global Investors LP increased its holdings in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Nordea Investment Management AB increased its position in HCA Healthcare by 5.2% during the 3rd quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock worth $415,656,000 after buying an additional 47,960 shares during the period. Pacer Advisors Inc. grew its stake in shares of HCA Healthcare by 6,115.3% in the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Finally, LSV Asset Management raised its holdings in HCA Healthcare by 0.4% in the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after acquiring an additional 3,396 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,214 shares of company stock valued at $7,797,595 over the last three months. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA opened a second freestanding emergency room in St. Augustine, Florida — expands lower‑acuity, higher‑margin outpatient/ER capacity and should support local volume growth. Becker’s: HCA opens 2nd freestanding ER in Florida county
• Positive Sentiment: HCA Florida opened another ER (Shoppes at Mission Trace), furthering the company’s outpatient/ER footprint and potential revenue capture. JaxDailyRecord: HCA Florida opens ER
• Positive Sentiment: Subsidiary acquisition of a cardiothoracic/vascular physician group should increase referrals and surgical volume to HCA hospitals — supportive for high‑acuity revenue. Becker’s: HCA subsidiary acquires cardiothoracic, vascular physician group
• Positive Sentiment: HCA is investing in EHR unification with peers — a multi‑year initiative that can lower IT/operational costs and improve billing/care coordination. Becker’s: Why Northwell, HCA and UPMC are betting big on EHR unification
• Positive Sentiment: Recent quarter: EPS beat and HCA set FY‑2026 guidance (29.10–31.50 EPS); MarketBeat coverage also noted a dividend increase — these are tangible fundamentals that support investor interest. MarketBeat: HCA earnings/dividend summary
• Neutral Sentiment: Analyst/style pieces (Zacks, Kalkine, Yahoo roundups) highlight HCA as a value/momentum name — useful for flow context but unlikely to move shares without new catalysts. Zacks: HCA is a strong value stock
• Neutral Sentiment: Local CSR/community activity (e.g., National Wear Red Day build) is positive for brand but has limited near‑term financial impact. Post and Courier: HCA community event
• Negative Sentiment: An HCA EVP, Michael R. McAlevey, disclosed sale of 1,694 shares (~$903k), trimming his stake ~16% — insider selling can trigger short‑term negative sentiment even if driven by personal reasons. InsiderTrades: Michael Mcalevey sells HCA shares
• Negative Sentiment: A critical opinion piece highlights ongoing safety failures at Mission Hospital — reputational/operational concerns can weigh on sentiment until addressed publicly. MSN: Opinion on Mission Hospital safety

Wall Street Analyst Weigh In

Several analysts recently weighed in on HCA shares. Argus upped their price objective on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. The Goldman Sachs Group raised their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Leerink Partners raised their price target on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Barclays lifted their target price on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Finally, TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Trading Up 0.0%

HCA opened at $534.88 on Thursday. The company has a market cap of $119.61 billion, a P/E ratio of 18.85, a price-to-earnings-growth ratio of 1.64 and a beta of 1.36. The company has a fifty day moving average price of $486.13 and a two-hundred day moving average price of $452.76. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $552.90.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the business posted $6.22 EPS. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.